The Senior Director, HIV Treatment Portfolio Strategy is responsible for defining and advancing the integrated portfolio strategy across Gilead's HIV Treatment brands. As the portfolio expands to include multiple complementary brands, this leader ensures brand strategies, investments, and commercial approaches work together intentionally to maximize long-term patient impact, portfolio value, and franchise growth while preserving clear brand-level ownership and accountability. This role serves as the enterprise integrator for the HIV Treatment business, partnering closely with Brand Leadership, Sales, Medical Affairs, Market Access, Insights & Analytics, Finance, Commercial Operations, and Global teams to identify portfolio opportunities, establish strategic priorities, guide investment and resource allocation decisions, and enable coordinated decision-making across brands. The role is accountable for portfolio direction, governance, prioritization, and strategic integration, while brand and capability leaders translate those priorities into specialized strategies, activation plans, and business outcomes. The Senior Director identifies and frames the portfolio's most consequential strategic choices, evaluates opportunities, risks, dependencies, and trade-offs across brands, and develops objective recommendations that enable timely executive decisions and coordinated organizational action. This includes assessing growth opportunities, competitive responses, investment trade-offs, and future priorities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director